Skip to main content
. 2021 Aug 6;160(6):2324–2331. doi: 10.1016/j.chest.2021.08.003

Table 1.

Demographic Characteristics of All Patients Referred for mAb Therapy and Subgroups of Referred Patients

Characteristics All Referred (N = 1,962) Offered Infusion (n = 480) Infused (n = 191) Patient Declined (n = 132)
Age, y 64.4 64.3 65.9 61.9
Female sex 1119 (57.0) 289 (60.3) 111 (58.1) 89 (67.9)
Race
 White 1582 (80.6) 375 (78.3) 151 (79.1) 101 (76.5)
 Black 113 (5.76) 35 (7.31) 17 (8.90) 7 (5.30)
 Asian 35 (1.78) 7 (1.46) 3 (1.57) 1 (0.76)
 Hispanic or Latino 26 (1.33) 4 (0.84) 0 1 (0.76)
 Other 104 (5.30) 31 (6.47) 11 (5.76) 12 (9.09)
 Unknown/declined 94 (4.79) 24 (49.0) 7 (3.66) 9 (6.82)
Ethnicity
 Hispanic or Latino 154 (7.85) 41 (8.56) 12 (6.28) 16 (12.1)
 Not Hispanic or Latino 1298 (66.2) 299 (62.4) 124 (64.9) 71 (53.8)
 Other 39 (1.99) 12 (2.92) 7 (3.66) 2 (1.52)
 Unknown/declined 508 (24.0) 125 (26.1) 45 (25.1) 43 (32.6)
Preferred language English 1728 (88.1) 414 (86.4) 169 (88.5) 112 (85.5)
Massachusetts resident 1822 (92.9) 445 (92.7) 182 (95.3) 125 (94.7)

Data are presented as No. (%) or mean. mAb = monoclonal antibody.